Clinical Trials › NCT05532943
RecruitingPhase 1
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Sponsored by Ever Supreme Bio Technology Co., Ltd.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 41
Target enrollment
Sep 2023
Start date
Oct 2028
Expected completion
Interventions / Treatments
Allogeneic umbilical cord mesenchymal stem cellsControl group
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.